USD 26.5
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 1601.68 Billion JPY | 25.28% |
2023 | 1278.47 Billion JPY | 22.36% |
2022 | 1044.89 Billion JPY | 8.56% |
2021 | 962.51 Billion JPY | -1.96% |
2020 | 981.79 Billion JPY | 5.6% |
2019 | 929.71 Billion JPY | -3.17% |
2018 | 960.19 Billion JPY | 0.53% |
2017 | 955.12 Billion JPY | -3.18% |
2016 | 986.44 Billion JPY | 7.3% |
2015 | 919.37 Billion JPY | 2.25% |
2014 | 899.12 Billion JPY | -9.6% |
2013 | 994.65 Billion JPY | 5.96% |
2012 | 938.67 Billion JPY | -2.97% |
2011 | 967.36 Billion JPY | 1.6% |
2010 | 952.1 Billion JPY | 13.06% |
2009 | 842.14 Billion JPY | -4.31% |
2008 | 880.12 Billion JPY | -5.31% |
2007 | 929.5 Billion JPY | 0.39% |
2006 | 925.91 Billion JPY | 57.51% |
2005 | 587.83 Billion JPY | -1.43% |
2004 | 596.34 Billion JPY | 4.64% |
2003 | 569.92 Billion JPY | 3.83% |
2002 | 548.89 Billion JPY | 0.7% |
2001 | 545.07 Billion JPY | -7.57% |
2000 | 589.73 Billion JPY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 350.83 Billion JPY | 6.25% |
2024 FY | 1601.68 Billion JPY | 25.28% |
2024 Q3 | 446.92 Billion JPY | 19.02% |
2024 Q4 | 428.41 Billion JPY | -4.14% |
2024 Q2 | 375.5 Billion JPY | 7.03% |
2023 Q4 | 330.2 Billion JPY | -3.02% |
2023 FY | 1278.47 Billion JPY | 22.36% |
2023 Q3 | 340.47 Billion JPY | 3.97% |
2023 Q2 | 327.48 Billion JPY | 16.82% |
2023 Q1 | 280.31 Billion JPY | 19.83% |
2022 Q2 | 265.89 Billion JPY | 0.69% |
2022 Q1 | 264.06 Billion JPY | 18.03% |
2022 Q4 | 233.92 Billion JPY | -16.75% |
2022 FY | 1044.89 Billion JPY | 8.56% |
2022 Q3 | 281 Billion JPY | 5.68% |
2021 Q1 | 236.94 Billion JPY | 5.42% |
2021 Q2 | 243.22 Billion JPY | 2.65% |
2021 Q3 | 258.62 Billion JPY | 6.33% |
2021 Q4 | 223.72 Billion JPY | -13.49% |
2021 FY | 962.51 Billion JPY | -1.96% |
2020 Q3 | 277.45 Billion JPY | 20.46% |
2020 Q2 | 230.33 Billion JPY | -7.59% |
2020 Q1 | 249.23 Billion JPY | 9.97% |
2020 FY | 981.79 Billion JPY | 5.6% |
2020 Q4 | 224.76 Billion JPY | -18.99% |
2019 Q4 | 226.63 Billion JPY | -11.55% |
2019 Q3 | 256.22 Billion JPY | 15.88% |
2019 Q2 | 221.11 Billion JPY | -2.05% |
2019 FY | 929.71 Billion JPY | -3.17% |
2019 Q1 | 225.73 Billion JPY | 3.01% |
2018 Q2 | 230.29 Billion JPY | -3.68% |
2018 Q4 | 219.14 Billion JPY | -19.33% |
2018 Q3 | 271.65 Billion JPY | 17.96% |
2018 FY | 960.19 Billion JPY | 0.53% |
2018 Q1 | 239.1 Billion JPY | 8.33% |
2017 Q4 | 220.71 Billion JPY | -20.14% |
2017 Q3 | 276.39 Billion JPY | 27.35% |
2017 Q2 | 217.04 Billion JPY | -9.93% |
2017 Q1 | 240.97 Billion JPY | 5.74% |
2017 FY | 955.12 Billion JPY | -3.18% |
2016 Q1 | 238.41 Billion JPY | 193.6% |
2016 Q4 | 227.89 Billion JPY | -18.55% |
2016 FY | 986.44 Billion JPY | 7.3% |
2016 Q3 | 279.77 Billion JPY | 16.4% |
2016 Q2 | 240.35 Billion JPY | 0.81% |
2015 FY | 919.37 Billion JPY | 2.25% |
2015 Q2 | 215.88 Billion JPY | 1.02% |
2015 Q3 | 264.8 Billion JPY | 22.66% |
2015 Q4 | 81.2 Billion JPY | -69.33% |
2015 Q1 | 213.7 Billion JPY | -31.32% |
2014 Q3 | 288.76 Billion JPY | 9.33% |
2014 Q1 | 252.63 Billion JPY | 0.17% |
2014 FY | 899.12 Billion JPY | -9.6% |
2014 Q4 | 311.17 Billion JPY | 7.76% |
2014 Q2 | 264.12 Billion JPY | 4.55% |
2013 Q2 | 241.55 Billion JPY | -0.44% |
2013 Q4 | 252.22 Billion JPY | -3.54% |
2013 FY | 994.65 Billion JPY | 5.96% |
2013 Q1 | 242.61 Billion JPY | 0.14% |
2013 Q3 | 261.46 Billion JPY | 8.24% |
2012 FY | 938.67 Billion JPY | -2.97% |
2012 Q1 | 231.66 Billion JPY | 5.63% |
2012 Q2 | 224.37 Billion JPY | -3.15% |
2012 Q3 | 240.36 Billion JPY | 7.12% |
2012 Q4 | 242.27 Billion JPY | 0.8% |
2011 Q3 | 249.16 Billion JPY | 2.77% |
2011 FY | 967.36 Billion JPY | 1.6% |
2011 Q4 | 219.3 Billion JPY | -11.98% |
2011 Q2 | 242.45 Billion JPY | -5.45% |
2011 Q1 | 256.42 Billion JPY | 13.24% |
2010 Q2 | 243.44 Billion JPY | 7.19% |
2010 Q3 | 255.09 Billion JPY | 4.79% |
2010 Q4 | 226.44 Billion JPY | -11.23% |
2010 FY | 952.1 Billion JPY | 13.06% |
2010 Q1 | 227.12 Billion JPY | 5.87% |
2009 Q2 | 202.59 Billion JPY | 0.0% |
2009 Q3 | 221.29 Billion JPY | 9.23% |
2009 Q4 | 214.52 Billion JPY | -3.06% |
2009 FY | 842.14 Billion JPY | -4.31% |
2008 FY | 880.12 Billion JPY | -5.31% |
2007 FY | 929.5 Billion JPY | 0.39% |
2006 FY | 925.91 Billion JPY | 57.51% |
2005 FY | 587.83 Billion JPY | -1.43% |
2004 FY | 596.34 Billion JPY | 4.64% |
2003 FY | 569.92 Billion JPY | 3.83% |
2002 FY | 548.89 Billion JPY | 0.7% |
2001 FY | 545.07 Billion JPY | -7.57% |
2000 FY | 589.73 Billion JPY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
AstraZeneca PLC | 46.91 Billion USD | -3314.043% |
Bristol-Myers Squibb Company PFD CONV 2 | 45 Billion USD | -3458.832% |
CSPC Pharmaceutical Group Limited | 31.45 Billion USD | -4992.79% |
Clarus Therapeutics Holdings, Inc. | 13.95 Million USD | -11475775.905% |
Novartis AG | 46.66 Billion USD | -3332.679% |
PT Kalbe Farma Tbk. | 1.97 Billion USD | -80826.288% |